Evidence map›Paper›PMID 32661077›Full record

ArticleJournal of bacteriology2020

Pseudomonas aeruginosa PA14 Enhances the Efficacy of Norfloxacin against Staphylococcus aureus Newman Biofilms.

Giulia Orazi, Fabrice Jean-Pierre, George A O'Toole

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Ability of Linezolid to CombatAntibiotics (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Review
  7. mBio · 2024
    Article
  8. Article
  9. We have a community problem.Journal of bacteriology · 2024
    Article
  10. bioRxiv : the preprint server for biology · 2024
    Article
  11. NorA efflux pump mediatesAntimicrobial agents and chemotherapy · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Biofilm Formation byInternational journal of molecular sciences · 2022
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Giulia OraziDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
Fabrice Jean-PierreDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
George A O'TooleDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA georgeo@dartmouth.edu.ORCID 0000-0002-2861-4392
Dartmouth College · US

Funding

HOST-MICROBE INTERACTIONST32AI007519 · NIAID · DARTMOUTH COLLEGE · PI DEBORAH A HOGAN · 1997 to 2026
$5.9M
cdiGMP regulation of Biofilm FormationR37AI083256 · NIAID · DARTMOUTH COLLEGE · PI O'TOOLE, GEORGE A. · 2014 to 2023
$4.7M
NIAID NIH HHS R37 AI083256NIAID NIH HHS T32 AI007519
6 · The paper itself

Abstract

The thick mucus within the airways of individuals with cystic fibrosis (CF) promotes frequent respiratory infections that are often polymicrobial.

Indexed as

Microbial InteractionsAnti-Bacterial AgentsBiofilmsDrug Resistance, BacterialNorfloxacinPseudomonas aeruginosaStaphylococcus aureusAnti-Bacterial AgentsNorfloxacinantibioticsbiofilmfluoroquinolonePseudomonas aeruginosaStaphylococcus aureus

Identifiers

PMID32661077
PMCPMC7925081
OpenAlexW3040880539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.